Literature DB >> 25227911

Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?

A Rashidi1, S I Fisher2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25227911     DOI： 10.1038/leu.2014.274

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  All-trans retinoic acid and early mortality in acute promyelocytic leukemia.

Authors:  Armin Rashidi; Ranjit K Goudar; Farzaneh Sayedian; Jeffrey A Vos; Teresa A Goldin; Nadine S Aguilera; Stephen I Fisher
Journal:  Leuk Res       Date:  2013-07-29       Impact factor: 3.156

2.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

3.  Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.

Authors:  E Di Bona; G Avvisati; G Castaman; M Luce Vegna; V De Sanctis; F Rodeghiero; F Mandelli
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

4.  Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Authors:  S Lehmann; A Ravn; L Carlsson; P Antunovic; S Deneberg; L Möllgård; A Rangert Derolf; D Stockelberg; U Tidefelt; A Wahlin; L Wennström; M Höglund; G Juliusson
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

5.  Treatment advances have not improved the early death rate in acute promyelocytic leukemia.

Authors:  James Scott McClellan; Holbrook E Kohrt; Steven Coutre; Jason R Gotlib; Ravindra Majeti; Ash A Alizadeh; Bruno C Medeiros
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

6.  Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.

Authors:  Rafael Henriques Jácomo; Raul Antonio Morais Melo; Fernanda Ribeiro Souto; Ederson Roberto de Mattos; Claudia Teresa de Oliveira; Evandro M Fagundes; Henrique Neves da Silva Bittencourt; Rosane Isabel Bittencourt; Teresa Cristina Bortolheiro; Eduardo J A Paton; Rodrigo Bendlin; Sebastião Ismael; Maria de Lourdes Chauffaille; Dirceu Silva; Katia Borgia B Pagnano; Raul Ribeiro; Eduardo M Rego
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

7.  Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States.

Authors:  Armin Rashidi; Meghan Riley; Teresa A Goldin; Farzaneh Sayedian; Michael G Bayerl; Nadine S Aguilera; Jeffrey A Vos; Ranjit K Goudar; Stephen I Fisher
Journal:  Leuk Res       Date:  2014-06-30       Impact factor: 3.156

8.  Acute promyelocytic leukemia in 57 previously untreated patients.

Authors:  C Cordonnier; J P Vernant; B Brun; M G Heilmann; M Kuentz; P Bierling; J P Farcet; M Rodet; N Duedari; M Imbert
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

9.  Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.

Authors:  Jessica K Altman; Alfred Rademaker; Elizabeth Cull; Bing Bing Weitner; Yishai Ofran; Todd L Rosenblat; Augustin Haidau; Jae H Park; Sharona Lee Ram; James M Orsini; Sonia Sandhu; Rosalind Catchatourian; Steven M Trifilio; Nelly G Adel; Olga Frankfurt; Eytan M Stein; George Mallios; Tony Deblasio; Joseph G Jurcic; Stephen Nimer; Loann C Peterson; Hau C Kwaan; Jacob M Rowe; Dan Douer; Martin S Tallman
Journal:  Leuk Res       Date:  2013-06-14       Impact factor: 3.156

10.  Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

Authors:  Javier de la Serna; Pau Montesinos; Edo Vellenga; Chelo Rayón; Ricardo Parody; Angel León; Jordi Esteve; Juan M Bergua; Gustavo Milone; Guillermo Debén; Concha Rivas; Marcos González; Mar Tormo; Joaquín Díaz-Mediavilla; Jose D González; Silvia Negri; Elena Amutio; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113
View more
  2 in total

1.  FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.

Authors:  A Rashidi; S I Fisher
Journal:  Blood Cancer J       Date:  2015-06-19       Impact factor: 11.037

2.  Analysis of early death in newly diagnosed acute promyelocytic leukemia patients.

Authors:  Fang Xu; Chunli Wang; Changxin Yin; Xuejie Jiang; Ling Jiang; Zhixiang Wang; Fanyi Meng
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.